| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282053 | Clinical Gastroenterology and Hepatology | 2013 | 4 Pages |
Abstract
Selection of triple therapy with either levofloxacin or rifabutin, based on results from bacterial culture tests, cures H pylori infection in about 90% who did not previously respond to antibiotics.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Giulia Fiorini, Nimish Vakil, Angelo Zullo, Ilaria M. Saracino, Valentina Castelli, Chiara Ricci, Cristina Zaccaro, Luigi Gatta, Dino Vaira,